Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study (Q44512277)

3 December 2017

Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study (English)

1 reference

3 December 2017

1 reference

S T Knudsen

1

1 reference

3 December 2017

T Bek

2

1 reference

3 December 2017

P Løgstrup Poulsen

3

1 reference

3 December 2017

M Nørgaard Hove

4

1 reference

3 December 2017

M Rehling

5

1 reference

3 December 2017

C E Mogensen

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Journal of Internal Medicine

3 December 2017

1 reference

3 December 2017

254

1 reference

3 December 2017

2

1 reference

3 December 2017

147-158

1 reference

Age-specific causes of bilateral visual impairment

3 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Quantitative assessment of macular edema with optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Reproducibility of retinal mapping using optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

The continuing epidemics of obesity and diabetes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Photocoagulation for Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Standardizing the measurement of visual acuity for clinical research studies: Guidelines from the Eye Care Technology Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Retinal neovascularization is prevented by blockade of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01192.X

10.1046/J.1365-2796.2003.01192.X

21 January 2018

Identifiers

DOI

1 reference

release_5fmkncxj3bh77ajv27lrudquze

3 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5fmkncxj3bh77ajv27lrudquze

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference